Literature DB >> 21278339

CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-α and IL-6 and promote cigarette smoke-induced emphysema.

Zeyu Xiong1, Adriana S Leme, Prabir Ray, Steven D Shapiro, Janet S Lee.   

Abstract

Increased numbers of macrophages are found in the lungs of smokers and those with chronic obstructive pulmonary disease. Experimental evidence shows the central role of macrophages in elaboration of inflammatory mediators such as TNF-α and the progression toward cigarette smoke-induced emphysema. We investigated the role of CX3CR1 in recruitment of mononuclear phagocytes, inflammatory cytokine responses, and tissue destruction in the lungs after cigarette smoke exposure. Using mice in which egfp is expressed at the locus of the cx3cr1 gene, we show that alveolar macrophages increased transmembrane ligand CX3CL1 expression and soluble CX3CL1 was detectable in the airspaces, but cx3cr1(GFP/GFP) and cx3cr1(GFP/+) mice failed to show recruitment of CX3CR1(+) cells into the airspaces with cigarette smoke. In contrast, cigarette smoke increased the accumulation of CX3CR1(+)CD11b(+) mononuclear phagocytes that were spatially confined to the lung interstitium and heterogenous in their expression of CD11c, MHC class II, and autofluorescent property. Although an intact CX3CL1-CX3CR1 pathway amplified the percentage of CX3CR1(+)CD11b(+) mononuclear phagocytes in the lungs, it was not essential for recruitment. Rather, functional CX3CR1 was required for a subset of tissue-bound mononuclear phagocytes to produce TNF-α and IL-6 in response to cigarette smoke, and the absence of functional CX3CR1 protected mice from developing tissue-destructive emphysema. Thus, CX3CR1(+) "tissue resident" mononuclear phagocytes initiate an innate immune response to cigarette smoke by producing TNF-α and IL-6 and are capable of promoting emphysema.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278339      PMCID: PMC3912553          DOI: 10.4049/jimmunol.1003221

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Distinct differentiation potential of blood monocyte subsets in the lung.

Authors:  Limor Landsman; Chen Varol; Steffen Jung
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation.

Authors:  E J Papadopoulos; C Sassetti; H Saeki; N Yamada; T Kawamura; D J Fitzhugh; M A Saraf; T Schall; A Blauvelt; S D Rosen; S T Hwang
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

3.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

Authors:  R D Hautamaki; D K Kobayashi; R M Senior; S D Shapiro
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Processing of tumour necrosis factor-alpha precursor by metalloproteinases.

Authors:  A J Gearing; P Beckett; M Christodoulou; M Churchill; J Clements; A H Davidson; A H Drummond; W A Galloway; R Gilbert; J L Gordon
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

5.  Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice.

Authors:  Thomas H March; Julie A Wilder; Dolores C Esparza; Patsy Y Cossey; Lee F Blair; Lois K Herrera; Jacob D McDonald; Matthew J Campen; Joe L Mauderly; Jeanclare Seagrave
Journal:  Toxicol Sci       Date:  2006-05-12       Impact factor: 4.849

6.  Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract.

Authors:  Christophe von Garnier; Luis Filgueira; Matthew Wikstrom; Miranda Smith; Jennifer A Thomas; Deborah H Strickland; Patrick G Holt; Philip A Stumbles
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.

Authors:  J K Harrison; Y Jiang; S Chen; Y Xia; D Maciejewski; R K McNamara; W J Streit; M N Salafranca; S Adhikari; D A Thompson; P Botti; K B Bacon; L Feng
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Elastin fragments drive disease progression in a murine model of emphysema.

Authors:  A McGarry Houghton; Pablo A Quintero; David L Perkins; Dale K Kobayashi; Diane G Kelley; Luiz A Marconcini; Robert P Mecham; Robert M Senior; Steven D Shapiro
Journal:  J Clin Invest       Date:  2006-02-09       Impact factor: 14.808

9.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.

Authors:  K Ohnishi; M Takagi; Y Kurokawa; S Satomi; Y T Konttinen
Journal:  Lab Invest       Date:  1998-09       Impact factor: 5.662

10.  Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.

Authors:  A M Fong; L A Robinson; D A Steeber; T F Tedder; O Yoshie; T Imai; D D Patel
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  32 in total

1.  Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.

Authors:  Sho Shibata; Kensuke Miyake; Tomoya Tateishi; Soichiro Yoshikawa; Yoshinori Yamanishi; Yasunari Miyazaki; Naohiko Inase; Hajime Karasuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

2.  Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation.

Authors:  Robert M Tighe; Zhuowei Li; Erin N Potts; Sarah Frush; Ningshan Liu; Michael D Gunn; W Michael Foster; Paul W Noble; John W Hollingsworth
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

3.  In vivo structure/function and expression analysis of the CX3C chemokine fractalkine.

Authors:  Ki-Wook Kim; Alexandra Vallon-Eberhard; Ehud Zigmond; Julia Farache; Elias Shezen; Guy Shakhar; Andreas Ludwig; Sergio A Lira; Steffen Jung
Journal:  Blood       Date:  2011-09-27       Impact factor: 22.113

4.  Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Authors:  Kunal J Patel; Qi Cheng; Sarah Stephenson; D Patterson Allen; Changhai Li; Jane Kilkenny; Ryan Finnegan; Valeria Montalvo-Calero; Scott Esckilsen; Chentha Vasu; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

5.  An agent-based model of inflammation and fibrosis following particulate exposure in the lung.

Authors:  Bryan N Brown; Ian M Price; Franklin R Toapanta; Dilhari R DeAlmeida; Clayton A Wiley; Ted M Ross; Tim D Oury; Yoram Vodovotz
Journal:  Math Biosci       Date:  2011-03-06       Impact factor: 2.144

6.  FcγRI (CD64): an identity card for intestinal macrophages.

Authors:  Jaime De Calisto; Eduardo J Villablanca; J Rodrigo Mora
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

7.  Selective and inducible targeting of CD11b+ mononuclear phagocytes in the murine lung with hCD68-rtTA transgenic systems.

Authors:  Alexandra L McCubbrey; Lea Barthel; Kara J Mould; Michael P Mohning; Elizabeth F Redente; William J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

Review 8.  The epigenetics of maternal cigarette smoking during pregnancy and effects on child development.

Authors:  Valerie S Knopik; Matthew A Maccani; Sarah Francazio; John E McGeary
Journal:  Dev Psychopathol       Date:  2012-11

Review 9.  Efferocytosis and lung disease.

Authors:  Alexandra L McCubbrey; Jeffrey L Curtis
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

10.  Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues.

Authors:  Yen-Rei A Yu; Danielle F Hotten; Yuryi Malakhau; Ellen Volker; Andrew J Ghio; Paul W Noble; Monica Kraft; John W Hollingsworth; Michael D Gunn; Robert M Tighe
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.